top of page
Search
Biologics R&D: select news
Utilization of exosome-based therapies to augment anti-PD-1/PD-L1 therapies
https://pubmed.ncbi.nlm.nih.gov/40280565/
jeanfrancoismaison
Apr 281 min read
GLP-1-based therapies for diabetes, obesity and beyond
https://pubmed.ncbi.nlm.nih.gov/40281304/
jeanfrancoismaison
Apr 281 min read
CAR-T Therapy for the Treatment of Colorectal Cancer
https://pubmed.ncbi.nlm.nih.gov/40287799/#full-view-affiliation-2
jeanfrancoismaison
Apr 281 min read
Breadth of immune response, immunogenicity, reactogenicity, and safety for a pentavalent meningococcal ABCWY vaccine in healthy adolescents and young adults: results from a phase 3, randomised, contro
https://pubmed.ncbi.nlm.nih.gov/39647494/#full-view-affiliation-20
jeanfrancoismaison
Apr 281 min read
B cell-expressed CD1d promotes MPL/TDCM lipid emulsion adjuvant effects in polysaccharide vaccines
https://pubmed.ncbi.nlm.nih.gov/40280183/
jeanfrancoismaison
Apr 281 min read
Structure, Function, and Regulation of LytA: The N-Acetylmuramoyl-l-alanine Amidase Driving the "Suicidal Tendencies" of Streptococcus pneumoniae-A Review
https://pubmed.ncbi.nlm.nih.gov/40284663/
jeanfrancoismaison
Apr 281 min read
Self-Amplifying RNA: Advantages and Challenges of a Versatile Platform for Vaccine Development
https://pubmed.ncbi.nlm.nih.gov/40285008/
jeanfrancoismaison
Apr 281 min read
A novel tolerogenic antigen-specific vaccine induces VISTA-enriched regulatory T cells and protects against arthritis in DRB1*04:01 mice
https://pubmed.ncbi.nlm.nih.gov/40285352/#full-view-affiliation-10
jeanfrancoismaison
Apr 281 min read
Vaccinology: Getting our modernization act together
https://pubmed.ncbi.nlm.nih.gov/40261250/
jeanfrancoismaison
Apr 231 min read
The novel antigen, lipopolysaccharide export protein LptH, protects mice against Pseudomonas aeruginosa acute pneumonia in monovalent and multivalent vaccines
https://pubmed.ncbi.nlm.nih.gov/40262371/
jeanfrancoismaison
Apr 231 min read
Liver-stage malaria transcriptomes: what you don't know can kill you
https://pubmed.ncbi.nlm.nih.gov/40263025/
jeanfrancoismaison
Apr 231 min read
The urease E subunit vaccine stimulate the immune response versus Helicobacter pylori in animal model
https://pubmed.ncbi.nlm.nih.gov/40259189/
jeanfrancoismaison
Apr 221 min read
Immunoengineering: An Emerging Field in Infectious Diseases
https://pubmed.ncbi.nlm.nih.gov/40259762/
jeanfrancoismaison
Apr 221 min read
Immunogenicity and safety of a multi-human dose formulation of Biological E's 14-valent pneumococcal polysaccharide conjugate vaccine (PNEUBEVAX 14®) administered to 6-8-week-old healthy infants: a ph
https://pubmed.ncbi.nlm.nih.gov/40260247/
jeanfrancoismaison
Apr 221 min read
Differential Response and Resistance to KRAS-Targeted Therapy
https://pubmed.ncbi.nlm.nih.gov/40256920/
jeanfrancoismaison
Apr 221 min read
Ratiometric Dual-Response Quantum Dot Spherical Nucleic Acid for Monitoring Viral Secondary Bacterial Infections
https://pubmed.ncbi.nlm.nih.gov/40257288/
jeanfrancoismaison
Apr 221 min read
CAR T cells re-directed by a rationally designed human peptide tag demonstrate efficacy in preclinical models
https://pubmed.ncbi.nlm.nih.gov/40257412/
jeanfrancoismaison
Apr 221 min read
Immune mediated inflammatory diseases: moving from targeted biologic therapy, stem cell therapy to targeted cell therapy
https://pubmed.ncbi.nlm.nih.gov/40260258/
jeanfrancoismaison
Apr 221 min read
AstraZeneca, Daiichi Sankyo Push Enhertu to Frontline Breast Cancer With Phase III Data
https://www.biospace.com/drug-development/astrazeneca-daiichi-sankyo-push-enhertu-to-frontline-breast-cancer-with-phase-iii-data?utm_camp...
jeanfrancoismaison
Apr 221 min read
Phase I dose-escalation and pharmacodynamic study of STING agonist E7766 in advanced solid tumors
https://pubmed.ncbi.nlm.nih.gov/39979069/
jeanfrancoismaison
Apr 211 min read
bottom of page